Cargando…
Myopathy, residual effect of rocuronium, or both? A possible ritonavir–rocuronium interaction interfering weaning from mechanical ventilation in a patient with COVID-19 pneumonia
Autores principales: | Domingo-Chiva, Esther, Monsalve-Naharro, José Ángel, Gerónimo-Pardo, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022060/ https://www.ncbi.nlm.nih.gov/pubmed/33840941 http://dx.doi.org/10.4103/joacp.JOACP_346_20 |
Ejemplares similares
-
Lopinavir/ritonavir/rocuronium bromide interaction: Myopathy following off-label use: case report
Publicado: (2021) -
Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020) -
Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015) -
‘Jaws of steel’ after rocuronium
por: Raut, Monish S, et al.
Publicado: (2016) -
Prevention of rocuronium injection pain
por: Park, Sungsik
Publicado: (2014)